AURISCO PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.69 CNY | -1.29% |
|
-6.55% | -8.25% |
Business Summary
Number of employees: 1,355
Sales per Business
| CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Cardiovascular
23.8
%
| 237 | 23.5 % | 300 | 23.8 % | +26.94% |
Anti-Tumor
19.3
%
| 141 | 14.0 % | 244 | 19.3 % | +73.63% |
Women's Health
15.0
%
| 194 | 19.3 % | 189 | 15.0 % | -2.86% |
Respiratory System
12.9
%
| 152 | 15.1 % | 163 | 12.9 % | +7.48% |
Trade
8.3
%
| 89 | 8.8 % | 105 | 8.3 % | +18.88% |
Preparation
7.1
%
| - | - | 90 | 7.1 % | - |
Nervous System
5.8
%
| 100 | 10.0 % | 74 | 5.8 % | -26.74% |
Other
5.5
%
| 42 | 4.1 % | 70 | 5.5 % | +68.13% |
Anti-infection
1.5
%
| 47 | 4.6 % | 18 | 1.5 % | -60.32% |
Other Business
0.7
%
| 7 | 0.7 % | 9 | 0.7 % | +18.90% |
Sales per region
| CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Overseas
86.9
%
| 928 | 92.1 % | 1,089 | 86.9 % | +17.40% |
China
13.1
%
| 80 | 7.9 % | 164 | 13.1 % | +105.38% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Ding Jun Chu
CEO | Chief Executive Officer | 51 | 17-05-31 |
Xiu Yu Wang
DFI | Director of Finance/CFO | 43 | 17-05-31 |
De Fa Zhang
CTO | Chief Tech/Sci/R&D Officer | 51 | 17-05-31 |
Guoping Wang
BRD | Director/Board Member | 58 | 17-05-31 |
Fang Fang Li
SEC | Corporate Secretary | 52 | 17-05-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Guoping Wang
BRD | Director/Board Member | 58 | 17-05-31 |
Yong Cheng Zhong
BRD | Director/Board Member | 60 | 23-05-04 |
Wei Ke Su
BRD | Director/Board Member | 63 | 23-05-04 |
Zhi An Peng
CHM | Chairman | 51 | 16-05-31 |
Yi Zhou Chu
BRD | Director/Board Member | 66 | 17-05-31 |
Pei Jing Qiu
BRD | Director/Board Member | 58 | 17-05-31 |
Ding Jun Chu
CEO | Chief Executive Officer | 51 | 17-05-31 |
Ping Jin
CHM | Chairman | 69 | 17-05-31 |
Li Wei Yang
BRD | Director/Board Member | 44 | 17-05-31 |
Jin Liang Li
BRD | Director/Board Member | 52 | 23-05-04 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 406,195,000 | 68,915,400 ( 16.97 %) | 4,156,000 ( 1.023 %) | 16.97 % |
Company contact information
Aurisco Pharmaceutical Co., Ltd.
Badu Industrial Zone
317200, Tiantai
+
http://www.aurisco.com/index.asp
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
23.69
CNY
Average target price
31
CNY
Spread / Average Target
+30.86%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.25% | 1.35B | |
| +32.36% | 709B | |
| +30.77% | 595B | |
| -1.60% | 367B | |
| +20.07% | 334B | |
| +6.04% | 289B | |
| +14.77% | 239B | |
| +9.13% | 211B | |
| -3.97% | 203B | |
| +9.27% | 171B |
- Stock Market
- Equities
- 605116 Stock
- Company Aurisco Pharmaceutical Co.,Ltd.